The U.S. Food and Drug Administration said on Wednesday that it has approved Bayer's drug for patients with a form of lung ...
The U.S. Food and Drug Administration on Wednesday said it has approved Bayer's drug for patients with a type of lung cancer ...
Some lung cancers manage to overcome a targeted drug therapy despite it showing initial success. Yale researchers have now ...
Approximately 20% of new lung cancer diagnoses occur in nonsmokers in the U.S., according to The Ohio State University ...
If everyone eligible had a lung cancer screening, 62,000 lives would be saved over five years, a new study shows.
Approval based on results of landmark Phase 3 C-POST trial that show Libtayo is first immunotherapy to significantly improve disease-free survival in CSCC in the adjuvant setting, reducing the risk of ...
A year after she quit smoking, Kim Swart thought the half-million cigarettes she smoked between high school and retirement ...
New artificial intelligence technology is helping diagnose the U.S.’s most deadly cancer sooner, greatly improving the ...
Summit Therapeutics' Ivonescimab targets non-small cell lung cancer through its dual anti-PD-1 plus anti-VEGF mechanism.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback